Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Ordinary shares, par value US$0.0001 per share
-
Shares outstanding
-
32.2M
-
Number of holders
-
3
-
Total shares
-
3.39K
-
Shares change
-
+292
-
Total reported value, excl. options
-
$224K
-
Value change
-
+$20.9K
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$66.22
Significant Holders of BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share (BLTE) as of Q1 2025
4 filings reported holding BLTE - BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share as of Q1 2025.
BELITE BIO, INC - Ordinary shares, par value US$0.0001 per share (BLTE) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.39K shares
of 32.2M outstanding shares and own 0.01% of the company stock.
Largest 4 shareholders include GAMMA Investing LLC (1.85K shares), RHUMBLINE ADVISERS (1.44K shares), SBI Securities Co., Ltd. (104 shares), and Mirae Asset Global Investments Co., Ltd. (0 shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.